These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 24691150)

  • 1. In brief: otrexup--a single-use auto-injector formulation of methotrexate.
    Med Lett Drugs Ther; 2014 Mar; 56(1439):28. PubMed ID: 24691150
    [No Abstract]   [Full Text] [Related]  

  • 2. [Subcutaneous self-administration of methotrexate in rheumatoid arthritis].
    Huisman AM; Schouten JP; van Paassen HC; Wouters JM; Jacobs JW
    Ned Tijdschr Geneeskd; 1996 Jul; 140(30):1564-5. PubMed ID: 8765767
    [No Abstract]   [Full Text] [Related]  

  • 3. Self-injection of gold and methotrexate.
    Arthur V; Jubb R; Homer D
    J Rheumatol; 2001 Jan; 28(1):212. PubMed ID: 11196528
    [No Abstract]   [Full Text] [Related]  

  • 4. Limitations of the study of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: comment on the article by Braun et al.
    Raghu P; Grover PS; Kumar A
    Arthritis Rheum; 2008 Jul; 58(7):2209; author reply 2209-10. PubMed ID: 18576338
    [No Abstract]   [Full Text] [Related]  

  • 5. Subcutaneous methotrexate is well tolerated and superior to oral methotrexate in the treatment of rheumatoid arthritis.
    Hameed B; Jones H
    Int J Rheum Dis; 2010 Oct; 13(4):e83-4. PubMed ID: 21199461
    [No Abstract]   [Full Text] [Related]  

  • 6. Bioavailability of higher dose MTX comparing oral and subcutaneous administration in patients with RA.
    Rau R
    J Rheumatol; 2005 Jul; 32(7):1412; author reply 1412-3. PubMed ID: 15996092
    [No Abstract]   [Full Text] [Related]  

  • 7. Comment on: Use of parenteral methotrexate significantly reduces the need for biological therapy.
    Thornton C; Ong V; Ward J; Kennedy N; Steuer A
    Rheumatology (Oxford); 2008 Sep; 47(9):1438; author reply 1438. PubMed ID: 18617550
    [No Abstract]   [Full Text] [Related]  

  • 8. Subtherapeutic dosing of methotrexate in rheumatoid arthritis trials.
    Parker CT; Mewshaw E; Dennis GJ
    J Am Osteopath Assoc; 2004 Jan; 104(1):7-8. PubMed ID: 14992316
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapy: oral or subcutaneous methotrexate for rheumatoid arthritis?
    Alsaeedi S; Keystone EC
    Nat Rev Rheumatol; 2014 Oct; 10(10):578-9. PubMed ID: 25090946
    [No Abstract]   [Full Text] [Related]  

  • 10. Why subcutaneous methotrexate should be a prerequisite to biologic use in patients with rheumatoid arthritis.
    Koduri GM; Mukhtyar C
    Rheumatology (Oxford); 2019 Apr; 58(4):559-560. PubMed ID: 29672739
    [No Abstract]   [Full Text] [Related]  

  • 11. Methotrexate in the Treatment of Psoriasis and Rheumatoid Arthritis: Mechanistic Insights, Current Issues and Novel Delivery Approaches.
    Rajitha P; Biswas R; Sabitha M; Jayakumar R
    Curr Pharm Des; 2017; 23(24):3550-3566. PubMed ID: 28571554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcutaneous methotrexate to cut costs?
    Hassanzadeh R; Mangan C; France J; Bawa S
    J Rheumatol; 2012 Aug; 39(8):1764-5. PubMed ID: 22859538
    [No Abstract]   [Full Text] [Related]  

  • 13. Parenteral methotrexate should be given before biological therapy.
    Griffin AJ; Erkeller-Yuksel F
    Rheumatology (Oxford); 2004 May; 43(5):678; author reply 678-9. PubMed ID: 15103040
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclosporine and methotrexate for severe rheumatoid arthritis.
    Malleson P
    N Engl J Med; 1995 Dec; 333(23):1567; author reply 1568-9. PubMed ID: 7477177
    [No Abstract]   [Full Text] [Related]  

  • 15. Methotrexate, hydroxychloroquine, and intramuscular gold in rheumatoid arthritis.
    Wassenberg S; Rau R
    J Rheumatol; 2003 Aug; 30(8):1891; author reply 1891-2. PubMed ID: 12913889
    [No Abstract]   [Full Text] [Related]  

  • 16. [Methotrexate: advantages of subcutaneous administration].
    Krüger K
    Z Rheumatol; 2008 Jul; 67(4):332-3. PubMed ID: 18443809
    [No Abstract]   [Full Text] [Related]  

  • 17. [Standardization of methotrexate administration in routine rheumatological practice].
    Murav'ev IuV
    Ter Arkh; 2011; 83(5):33-7. PubMed ID: 21780654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using video-based training for button-free auto-injection of subcutaneous methotrexate: A pilot study.
    Homer D
    Musculoskeletal Care; 2019 Sep; 17(3):247-279. PubMed ID: 31373433
    [No Abstract]   [Full Text] [Related]  

  • 19. Should aggressive therapy for rheumatoid arthritis require early use of weekly low-dose methotrexate, as the first disease-modifying anti-rheumatic drug in most patients?
    Pincus T; Sokka T
    Rheumatology (Oxford); 2006 May; 45(5):497-9. PubMed ID: 16537578
    [No Abstract]   [Full Text] [Related]  

  • 20. A phase IB clinical trial with Dekavil (F8-IL10), an immunoregulatory 'armed antibody' for the treatment of rheumatoid arthritis, used in combination wiIh methotrexate.
    Galeazzi M; Bazzichi L; Sebastiani GD; Neri D; Garcia E; Ravenni N; Giovannoni L; Wilton J; Bardelli M; Baldi C; Selvi E; Iuliano A; Minisola G; Caporali R; Prisco E; Bombardieri S
    Isr Med Assoc J; 2014 Oct; 16(10):666. PubMed ID: 25438467
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.